Daniel D. Burton is CEO at Health Catalyst, Inc. (HCAT). They have made 18 open-market trades across 1 company since 2020, most recently 2025-12-01.
CIK 0001780980
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $11.3M since 2022, against 13 sales. Across 5 scored buys the stock is down 4.2% at ninety days, and 5.1 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| HCAT | 1,393,099 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2025-12-03 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 40% |
| Avg Move | -3.4% | -4.5% | -4.2% |
| Alpha | -2.9% | -3.2% | -5.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCAT | BUY | 2024-02-27 | 2024-02-27 | $7.81 | $205K | +1.9% | -12.2% | -20.4% |
| HCAT | BUY | 2023-05-12 | 2023-05-12 | $10.19 | $1000K | +2.7% | +9.5% | +15.1% |
| HCAT | BUY | 2022-11-11 | 2022-11-14 | $10.14 | $4.0M | -4.1% | +9.7% | +36.8% |
| HCAT | BUY | 2022-09-08 | 2022-09-08 | $10.99 | $2.0M | -12.9% | -19.4% | -8.1% |
| HCAT | BUY | 2022-08-09 | 2022-08-09 | $11.62 | $4.1M | -4.5% | -10.1% | -44.6% |
| HCAT | SELL | 2021-12-07 | 2021-12-09 | $40.47 | $1.3M | +0.9% | -12.0% | -32.8% |
| HCAT | SELL | 2021-12-03 | 2021-12-07 | $40.41 | $4.7M | -4.4% | -10.8% | -37.3% |
| HCAT | SELL | 2021-09-03 | 2021-09-08 | $54.40 | $6.9M | -1.0% | -12.5% | -26.0% |
| HCAT | SELL | 2021-06-07 | 2021-06-09 | $55.29 | $4.8M | -2.1% | +0.9% | -4.9% |
| HCAT | SELL | 2021-06-03 | 2021-06-07 | $52.91 | $18.0M | -1.3% | +0.8% | -2.4% |
| HCAT | SELL | 2021-03-02 | 2021-03-03 | $47.62 | $136K | +2.7% | +3.2% | +14.4% |
| HCAT | SELL | 2020-12-01 | 2020-12-03 | $35.21 | $1.5M | +5.2% | +16.6% | +29.4% |
| HCAT | SELL | 2020-08-24 | 2020-08-27 | $30.38 | $7.3M | +7.0% | +19.4% | +16.0% |
| HCAT | SELL | 2020-08-20 | 2020-08-24 | $32.22 | $7.9M | +11.3% | +14.2% | +16.4% |
| HCAT | SELL | 2020-08-18 | 2020-08-20 | $32.52 | $9.7M | -0.7% | +5.9% | +2.4% |
| HCAT | SELL | 2020-08-14 | 2020-08-18 | $31.82 | $10.9M | -6.1% | +9.6% | +3.7% |
| HCAT | SELL | 2020-07-30 | 2020-08-03 | $35.37 | $14.2M | -9.6% | -7.6% | -5.3% |
| HCAT | SELL | 2020-06-25 | 2020-06-29 | $30.90 | $8.7M | +23.4% | +30.3% | +33.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.